NARA Discovery
Article Details
← Back to Search Results
Journal Article

Inhibition of p38 MAPK decreases hyperglycemia-induced nephrin endocytosis and attenuates albuminuria

Magdalena Patrycja Woznowski; Sebastian Alexander Potthoff; Eva Königshausen; Raphael Haase; Henning Hoch; Catherine Meyer-Schwesinger; Thorsten Wiech; Johannes Stegbauer; Lars Christian Rump; Lorenz Sellin; Ivo Quack
Journal of Molecular Medicine · Vol. 100, Issue 5 · pp. 781-795 · 2022

Abstract

Chronic hyperglycemia, as in diabetes mellitus, may cause glomerular damage with microalbuminuria as an early sign. Noteworthy, even acute hyperglycemia can increase glomerular permeability before structural damage of the glomerular filter can be detected. Despite intensive research, specific antiproteinuric therapy is not available so far. Thus, a deeper understanding of the molecular mechanisms of albuminuria is desirable. P38 MAPK signaling is involved in the development of hyperglycemia-induced albuminuria. However, the mechanism of increased p38 MAPK activity leading to increased permeability and albuminuria remained unclear. Recently, we demonstrated that acute hyperglycemia triggers endocytosis of nephrin, the key molecule of the slit diaphragm, and induces albuminuria. Here, we identify p38 MAPK as a pivotal regulator of hyperglycemia-induced nephrin endocytosis. Activated p38 MAPK phosphorylates the nephrin c-terminus at serine 1146, facilitating the interaction of PKCα with nephrin. PKCα phosphorylates nephrin at threonine residues 1120 and 1125, mediating the binding of β-arrestin2 to nephrin. β-arrestin2 triggers endocytosis of nephrin by coupling it to the endocytic machinery, leading to increased glomerular permeability. Pharmacological inhibition of p38 MAPK preserves nephrin surface expression and significantly attenuates albuminuria. Key messages Acute hyperglycemia triggers endocytosis of nephrin. Activated p38 MAPK phosphorylates the nephrin c-terminus at serine 1146, facilitating the interaction of PKCα with nephrin. PKCα phosphorylates nephrin at threonine residues 1120 and 1125, mediating the binding of β-arrestin2 to nephrin. β-arrestin2 triggers endocytosis of nephrin by coupling it to the endocytic machinery, leading to a leaky glomerular filter. Pharmacological inhibition of p38 MAPK preserves nephrin surface expression and significantly attenuates albuminuria under hyperglycemic conditions.

Bibliographic Information

JournalJournal of Molecular Medicine
PublisherSpringer
Publication Date2022-05-01
Publication Year2022
Volume100
Issue5
Pages781-795
Document TypeJournal Article
Print ISSN0946-2716
eISSN1432-1440
DOI10.1007/s00109-022-02184-5

Access Information

NARA Access Coverage1922-01-01~Current
Journal Homepagehttps://www.springer.com/journal/109
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.